ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,144.38
2.07%
S&P 500
5,246.28
-0.59%
Dow Jones
38,287.78
-1.03%
US Dollar vs Yen
156.1295
-0.67%
Brent Oil
78.345
-3.04%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Larimar Therapeutics Inc (LRMR)

  7. Larimar Therapeutics Inc (LRMR) ニュース

LRMR

Larimar Therapeutics (LRMR)

Larimar Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:LRMR
日付受信時刻ニュースソース見出しコード企業名
2024/06/0105 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
2024/06/0105 : 56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
2024/06/0105 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
2024/05/3105 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
2024/05/2813 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LRMRLarimar Therapeutics Inc
2024/05/2105 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
2024/05/1005 : 50Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LRMRLarimar Therapeutics Inc
2024/05/0920 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
2024/03/1205 : 09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
2024/02/1706 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
2024/02/1510 : 57Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LRMRLarimar Therapeutics Inc
2024/02/1507 : 08Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LRMRLarimar Therapeutics Inc
2024/02/1422 : 55Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LRMRLarimar Therapeutics Inc
2024/02/1420 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
2024/02/1406 : 46Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LRMRLarimar Therapeutics Inc
2024/02/1221 : 03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
2024/01/2006 : 33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
2024/01/2006 : 32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
2024/01/2006 : 31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
2024/01/2006 : 31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
2023/12/0906 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
2023/11/1503 : 51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LRMRLarimar Therapeutics Inc
2023/10/0405 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
2023/08/1421 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
2023/08/1105 : 05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LRMRLarimar Therapeutics Inc
2023/08/1020 : 03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
2023/07/2602 : 06Dow Jones NewsLarimar Therapeutics Shares Rise 10% After FDA Clears CTI-1601 TrialNASDAQ:LRMRLarimar Therapeutics Inc
2023/07/2520 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
2023/07/1905 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
2023/07/1905 : 13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LRMR

最近閲覧した銘柄

ASX
MZMN
ASX
JBY
James Bay Minerals
ASX
NEWDA
New Energy Solar
NASDAQ
CVV
CVD Equipment
LSE
GW14
Citi Fun 24
USOTC
SGCPF
Solstice Gold (PK)
NASDAQ
MARSB
Marsh Supermarkets
TG
HDD
Heidelberger Druckmaschi...
BOV
BDLL4F
BARDELLA PN
DGFX
MZTUSDT
Meta Z Token
LSE
3LCO
Coinbase 3xl $
BIT
UC59VV
Unicredit Bank
KOSPI
530063
Leverage Copper Futures ...
TSXV
CJX.P
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有